Overview

Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC

Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of novel DNA demethylating agents in the treatment of metastatic TNBC
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
Azacitidine
Carboplatin
Decitabine